To Get Help Now
Click Here
 
Today's Date:

J&J Facing Texas Risperdal Lawsuit

AddThis Social Bookmark Button

Johnson & Johnson is currently facing $660 million in Risperdal marketing judgments, and another $1 billion in settlement negotiations with the Justice Department. Though some states will share in the billion-dollar settlement, Texas has joined a whistleblower lawsuit against the company and is seeking its own $1 billion in potential damages.

The whistleblower lawsuit alleges Johnson & Johnson used a variety of inappropriate marketing strategies that had caused the state’s Medicaid program to overpay for the antipsychotic drug Risperdal, Bloomberg reports.

Charging the company under the False Claims Act, Texas Attorney General Greg Abbott says J&J pushed Risperdal for off-label uses that were not approved by the FDA. Abbott said the company marketed the drug as a treatment for dementia, and for use in children with psychiatric disorders. He said the company also paid state officials to get the drug into state formularies, and overstated the safety and efficacy of the drug.

A J&J spokesperson told Bloomberg, “We are committed to ethical business practices, and have policies in place to ensure that our products are only promoted for their FDA-approved indication.” She also said that the company takes “appropriate disciplinary action,” when its marketing policies are violated.

 

 

breakinglawsuitnews.com disclaimer: This article: J&J Facing Texas Risperdal Lawsuit was posted on Tuesday, January 10th, 2012 at 9:22 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Comments are closed.